publication venue for
- Opioid Agonist Treatment Retention Among People Initiating Methadone and Buprenorphine Across Diverse Demographic and Geographic Subgroups in Ontario: A Population-based Retrospective Cohort Study. 14:44-54. 2023
- Exploring the Bi-Directional Associations Between Poly-Substance Use and Symptoms of Anxiety and Depression Among a Large Sample of Canadian Adolescents. 13:7-16. 2022
- Theory and Practice of Treatment of Concurrent Major Depressive and Alcohol Use Disorders: 7 Lessons from Clinical Practice and Research. 12:39-46. 2021
- Is All “Safe Supply” Safe?. 11:30-31. 2020
- Cannabis Use in Patients Seeking Therapy for Anxiety and Related Disorders: A Descriptive Study. 10:30-37. 2019
- Cannabis and Mental Health: An Introduction to the Special Issue. 10:4-5. 2019
- Priorities for a Comprehensive Post-Legalization Cannabis Research Agenda in Canada. 10:67-71. 2019
- Clarifying the Relation Between Alcohol Demand and Alcohol-related Relative Reinforcement and Driving After Drinking in a Canadian Community Sample. 10:16-23. 2019
- Cannabis Legalization in Canada: The Public Health Approach We Did Not Get. 10:51-59. 2019
- Cannabis-Impaired Driving in Canada: Methodological Challenges and Emerging Research Priorities. 9:15-17. 2018
- PAUSE: The Development and Implementation of a Novel Brief Intervention Program Targeting Cannabis and Alcohol Use Among University Students ORIGINAL STUDY. 9:34-42. 2018
- Glass-Box Testing the Centre for Addiction and Mental Health Integrated Care Pathway for Major Depressive and Alcohol Use Disorders: Is It More Than a Sum of Its Components?. 9:7-17. 2018
- Adaptation of an Acute Psychiatric Unit to a Concurrent Disorders Unit to Increase Capacity and Improve Patient Care. 7:25-33. 2016
- Variability of QT interval measurements in opioid-dependent patients on methadone. 5:10-16. 2014